Visible Genetics shares jump 7%
Article Abstract:
Toronto, Ont.-based Visible Genetics Inc. expects to receive approval for a new HIV test kit from the U.S. Food and Drug Administration. Visible Genetics, which saw its share price soar, is developing a gene typing and sequencing system for HIV.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Odyssey nears end for cancer researcher
Article Abstract:
Ann Arbor, Mich.-based Biotherapies Inc. has announced that it will apply for a US license to distribute its new breast cancer diagnostic kits. Biotherapies asserts that mammastatin therapy will transform breast cancer treatment.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Biotech bets on AIDS treatment kit
Article Abstract:
Toronto-based Visible Genetics Inc. has emerged as a top genetics company with the introduction of the first genetic test kit designed to assist physicians with mixing drugs for AIDS patients.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Investors ignore eBay's solid earnings. Impotence treatment wins patent. E-retailers run low on fuel
- Abstracts: Impatient P&G ousts Jager. GE posts record profit; Welch sets retirement date. From emperor to outcast
- Abstracts: Airline pursue the trail of bucks. Charter flights being sold one seat at a time. Reagan National stretches west with new non-stops
- Abstracts: United mechanics' disputes spark FAA safety inquiry. Northwest on approach to labor peace
- Abstracts: TD appoints Clark to No. 2 job. Bloomberg quits National Bank unit. Two BMO veterans leave jobs in shuffle